TC Biopharm (Holdings) Plc

DB:T0U0 Stock Report

Market Cap: €3.8m

TC Biopharm (Holdings) Management

Management criteria checks 3/4

TC Biopharm (Holdings)'s CEO is Bryan Kobel, appointed in Jun 2021, has a tenure of 3.33 years. total yearly compensation is £427.17K, comprised of 83.3% salary and 16.7% bonuses, including company stock and options. directly owns 0.44% of the company’s shares, worth €16.53K. The average tenure of the management team and the board of directors is 3 years and 2.4 years respectively.

Key information

Bryan Kobel

Chief executive officer

UK£427.2k

Total compensation

CEO salary percentage83.3%
CEO tenure3.3yrs
CEO ownership0.4%
Management average tenure3yrs
Board average tenure2.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Bryan Kobel's remuneration changed compared to TC Biopharm (Holdings)'s earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-UK£9m

Dec 31 2023UK£427kUK£356k

-UK£6m

Sep 30 2023n/an/a

-UK£4m

Jun 30 2023n/an/a

-UK£2m

Mar 31 2023n/an/a

-UK£2m

Dec 31 2022UK£436kUK£363k

-UK£1m

Compensation vs Market: Bryan's total compensation ($USD560.73K) is about average for companies of similar size in the German market ($USD499.40K).

Compensation vs Earnings: Bryan's compensation has been consistent with company performance over the past year.


CEO

Bryan Kobel (45 yo)

3.3yrs

Tenure

UK£427,169

Compensation

Mr. Bryan Leland Kobel serves as Chief Executive Officer at TC Biopharm Limited. Mr. Kobel serves as Chief Executive Officer of TC Biopharm (Holdings) Plc since June 2021 and serves as Director. He joined...


Leadership Team

NamePositionTenureCompensationOwnership
Bryan Kobel
CEO & Director3.3yrsUK£427.17k0.44%
£ 16.5k
Martin Thorp
CFO & Director5.6yrsUK£322.02k0.00018%
£ 6.8
Christopher Camarra
Executive Vice President of Communications2.8yrsno datano data
Lauren Bor
Head of Commercial Development Divisionless than a yearno datano data

3.0yrs

Average Tenure

Experienced Management: T0U0's management team is considered experienced (3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Bryan Kobel
CEO & Directorno dataUK£427.17k0.44%
£ 16.5k
Martin Thorp
CFO & Director8.6yrsUK£322.02k0.00018%
£ 6.8
Arlene Morris
Non-Executive Independent Chair2.7yrsUK£23.53k0%
£ 0
Mark Bonyhadi
Chairman of Scientific Advisory Board2.4yrsUK£23.53k0%
£ 0
A. Culverwell
Non-Executive Independent Director2.7yrsUK£23.53k0%
£ 0
Isabelle Riviere
Member of Scientific Advisory Board2yrsno datano data
Daniel Olive
Member of Scientific Advisory Board2yrsno datano data
Uma Lakshmipathy
Member of Scientific Advisory Board2.4yrsno datano data
Erin Adams
Member of Scientific Advisory Board2.4yrsno datano data
Blythe Sather
Member of Scientific Advisory Board2yrsno datano data
Chris Bond
Member of Scientific Advisory Board2yrsno datano data

2.4yrs

Average Tenure

70yo

Average Age

Experienced Board: T0U0's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.